Free express shipping over $500 AUD

Resource · Updated 27 August 2026

How to Read a Peptide COA & Laboratory Test Report

A plain-English guide to the numbers, terms and documents that accompany research peptides — what a Certificate of Analysis can and cannot tell you, and how to read one without overstating what it proves.

What is a Certificate of Analysis?

A Certificate of Analysis (COA, also written CoA) is a document issued by a testing laboratory that reports the results of analytical testing performed on a specific sample. In the context of research peptides, a COA typically answers two distinct questions: how pure is this material, and is it actually the compound it is described as.

A COA is a report of a measurement taken at a point in time. It describes the sample that was submitted and tested — it is not a blanket guarantee about every vial that later carries the same name. Understanding that distinction is the single most useful thing to carry into reading any COA.

What information is normally included

Most peptide COAs share a common set of fields, though layout and completeness vary by laboratory:

  • Product name and description — what was tested and how it is described.
  • Batch / lot number — links the report to a production batch.
  • Sample ID — the identifier the laboratory assigned to the received sample.
  • Test date(s) — when analysis was performed.
  • Method(s) — e.g. HPLC, MS, or a named pharmacopeia method.
  • Results — purity percentage, observed mass, or other values.
  • Laboratory information — the name and, ideally, accreditation details.
  • Signatory / review — an approving individual or position.

A COA that carries all of these is substantially more useful than one that reports only a single purity figure with no method, no batch and no issuing laboratory.

Purity vs potency

Purity answers a relative question: of the peptide material present, what fraction matches the target compound? It is usually reported as a percentage of chromatographic peak area — for example, a 98% main peak means the target peptide accounts for 98% of the detected peptide signal.

Potency (often reported as “peptide content” or “net peptide content”) answers an absolute question: how much of the sample, by weight, is actually the target peptide once counter-ions, salts and residual water are excluded. A sample can be 98% pure yet contain noticeably less than the labelled total weight as peptide, because a peptide is usually supplied as a salt (acetate or trifluoroacetate) plus bound water.

The two numbers measure different things and are not interchangeable. Treating purity as if it were total peptide mass is one of the most common misreadings of a COA.

What HPLC testing means

High-performance liquid chromatography (HPLC) separates the components of a sample based on how strongly each interacts with a column and a moving solvent. The result is a chromatogram, in which each component appears as a peak; the area of each peak is proportional to the amount of that component present.

HPLC is the standard method for reporting peptide purity. A “98.5%” result means the main peak — assumed to be the target peptide — represents 98.5% of total peak area. It does not, on its own, confirm that the main peak is in fact the intended peptide; that identification question is answered separately (see below).

What mass spectrometry may show

Mass spectrometry (MS) measures the mass of a molecule, most typically after ionising it and determining its mass-to-charge ratio (m/z). For a peptide, the observed mass is compared against the theoretical molecular weight computed from its amino-acid sequence. A close match provides strong evidence that the sample contains the correct compound.

This is the essential complement to HPLC. HPLC says “there is a dominant component at 98.5%”; MS says “and that component has the mass of the expected peptide.” A purity figure without an identity measurement leaves open the question of whether the right molecule is present at all.

Batch and sample identification

Two identifiers matter and are easy to confuse. The batch number (or lot number) is assigned by the manufacturer to a production run. The sample ID is assigned by the laboratory to the specific aliquot it received for testing. They are deliberately separate: many samples across many batches may pass through a laboratory, and the sample ID lets the lab track its own work while the batch number links the result back to production.

On a well-formed COA both appear, and the report can only be meaningfully associated with a product when the batch number on the report matches the batch number on the physical product.

Test dates and report/reference numbers

A COA should carry the date the analysis was performed, and often a report number or reference number that the laboratory uses to retrieve the record. The date tells you whether the result is current for the batch in question; a report number is useful when you want to ask the laboratory about a specific document.

If the batch has been produced again since the tested batch, an old COA may not describe the material currently in hand. The date, combined with the batch number, is what lets you judge this.

Laboratory information

A useful COA names the laboratory that performed the testing and, where applicable, its accreditation (for example, ISO/IEC 17025 for testing laboratories). Accreditation signals that the laboratory operates under a recognised quality-management framework for its testing competence.

Knowing the laboratory also tells you whether the result is independent of the supplier or produced in-house — a distinction worth understanding, and covered in more detail below.

How to identify which batch a report relates to

Match a report to a physical product using three fields, in order:

  1. The product name on the report against the product in hand.
  2. The batch number on the report against the batch number on the packaging or vial.
  3. The test date, to confirm the report is current for that batch.

If the batch number isn't visible on the product or doesn't match the report, the report can't be confidently tied to that material — regardless of how impressive the headline purity figure is.

Why two laboratories may show slightly different values

It is normal for two laboratories testing nominally identical material to report slightly different numbers. Reasons include:

  • Method differences — different columns, gradients, or detection wavelengths.
  • Sample handling — moisture uptake, freeze-thaw history, or how the sample was prepared.
  • Reference standard — a different or differently-characterised reference shifts the comparison.
  • Integration choices — how peak baselines are drawn changes the reported area.
  • Inherent measurement uncertainty — every analytical method carries a margin of error.

Small differences (a fraction of a percent in purity) are usually unremarkable. Large, directionally-consistent differences, however, are worth investigating — they may indicate real differences in material or in how it was handled.

Common terminology on laboratory reports

Reports use a shared vocabulary. The quick-reference table at the bottom of this page collects the terms that appear most often; a fuller alphabetical treatment is available in the research glossary. Terminology that frequently causes confusion:

  • “Purity ≥98%” — a threshold statement, not an exact value; ask for the actual figure and chromatogram.
  • “Assay” or “content” — usually a quantitative measure of how much target material is present, closer to potency than purity.
  • “Conforms to specification” — the result met a defined acceptance criterion; the criterion itself should be stated.

Why the testing method matters

A purity number is only as meaningful as the method behind it. Different methods resolve different things: reversed-phase HPLC separates by hydrophobicity; ion-exchange separates by charge; size-exclusion separates by size. A method that cannot distinguish the target peptide from a closely related impurity can report a deceptively high purity.

When a COA states both the method and (ideally) the conditions, a reader can judge whether the reported purity actually addresses the question they care about. This is why bare “99% pure” claims, with no method, should be treated cautiously.

Supplier documentation vs independent testing

Supplier (or manufacturer) documentation is produced or supplied by the party selling the material — it may include internal QC reports or documents forwarded from a manufacturer. It is useful background but is not independent.

Independent testing is performed by a third-party laboratory with no stake in the sale, on samples the buyer (or a third party) submits. Because the laboratory has no incentive to flatter the result, independent reports carry materially more weight when you want reassurance about what a sample contains.

Both have a place; the key is to know which you are looking at and to weigh them accordingly. A document that does not identify its source laboratory cannot be evaluated on this axis at all.

Things that should invite scrutiny

Missing or blank batch number

A COA that cannot be tied to a specific production batch has limited traceability value.

No laboratory name

An anonymous report cannot be independently corroborated.

No date, or an implausible date

Undated results make it impossible to know whether testing is current.

Purity stated with no method

“99% pure” is meaningless without a stated method (e.g. HPLC) and conditions.

Only the main peak is reported

A single-number result without a chromatogram hides what else is present.

Potency and purity confused

Treating a purity percentage as if it were total peptide content misstates what was measured.

No reference standard mentioned

Purity comparisons depend on how the reference was characterised.

Internal lab that is also the seller

This is not automatically wrong, but it is not independent verification either.

How to interpret results without overstating what they prove

A COA supports a limited set of conclusions. It can support:

  • The tested sample’s purity at the time of testing.
  • The tested sample’s identity, where MS is included.
  • The tested sample’s peptide content, where assayed.

It does not, by itself, establish:

  • The properties of a different, untested batch.
  • Stability over time, unless stability was specifically tested.
  • Any biological effect, therapeutic claim, or suitability for human use.

The disciplined reading is to state exactly what was measured and for which sample — and to resist generalising beyond it. That restraint is precisely what makes the document trustworthy.

Quick-reference glossary

A concise table of the most common terms on a peptide COA. For a full A–Z treatment, see the research glossary.

TermWhat It Means
PurityPercentage of the tested material matching the target compound, typically measured by HPLC peak area.
PotencyAmount of target material actually present in the sample (often by weight), as opposed to its proportion.
HPLCHigh-performance liquid chromatography — an analytical method used to separate and measure compounds in a mixture.
Retention TimeThe time a compound takes to pass through the test system; a characteristic fingerprint under fixed conditions.
Mass Spectrometry (MS)A method that measures molecular mass to confirm the identity of a compound.
Batch NumberIdentifier linking material to a specific production batch.
Sample IDIdentifier assigned to the specific sample submitted to the laboratory.
ChromatogramThe graphical output of HPLC — peaks whose areas correspond to component amounts.
Reference StandardA characterised, known-purity sample used to calibrate or compare against.
Peptide ContentActual peptide weight in the sample, excluding counter-ions, salts and residual water.
Counter-IonAn associated ion (e.g. acetate, trifluoroacetate) that adds weight but is not peptide material.
Molecular WeightMass of a single molecule in Daltons (Da); MS compares measured mass against this.
Method / SOPThe documented procedure used for testing; noted so results can be reproduced.
Limit of DetectionThe smallest amount of a substance the method can reliably distinguish from background.

Citing this resource

If you reference this guide, a suggested citation:

Bulk Aussie Peptides. “How to Read a Peptide COA & Laboratory Test Report.” Updated 27 August 2026. https://www.bulkaussiepeptides.com.au/resources/peptide-coa-testing-guide

Sources & references

General background used to prepare this guide. Statements about analytical method are standard laboratory-chemistry knowledge; these sources provide formal definitions and accreditation framework.

  • ISO/IEC 17025:2017 — General requirements for the competence of testing and calibration laboratories. International Organization for Standardization. iso.org/standard/66912
  • IUPAC. Compendium of Chemical Terminology (the “Gold Book”) — definitions of chromatographic and spectrometric terms. goldbook.iupac.org
  • U.S. Food and Drug Administration. Guidance for Industry — Analytical Procedures and Methods Validation (reference on method validation and reporting). fda.gov